LG Life Science’s partnership for the ‘Humira biosimilar’ with Mochida in Japan

Published: 2014-10-17 13:51:56

Updated: 2014-10-17 13:51:56

On the 15th, LG Life Science Ltd. (CEO: Il-jae Jung) announced that it made a partnership with a Japanese company, Mochida, to develop and sell the Humira biosimilar, a global drug for autoimmune disease.

Through the partnership, Mochida will secure exclusive rights in Japan to develop and sell Humira biosimilar products, currently undergoing clinical development in LG Life Science; in additio...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.